×

How biotechs are affecting J&J's business

1:55 PM ET Wed, 20 May 2015

Michael Weinstein, JPM, managing director of healthcare, joins CNBC's Meg Tirrell to discuss biosimilar, the threat to big pharmaceuticals, and how Johnson & Johnson will be affected.